AL
DOCU

Aspiriant LLC’s DocuSign DOCU Stock Holding History

Aspiriant LLC’s Portfolio DOCU Stock Details DOCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,183
Closed -$423K – 342
2025
Q4 		$423K Sell
6,183
-3,917
-39% -$271K 0.01% 235
2025
Q3 		$728K Sell
10,100
-17
-0.2% -$1.31K 0.02% 174
2025
Q2 		$788K Buy
10,117
+3
+0% +$243 0.03% 164
2025
Q1 		$823K Buy
10,114
+12
+0.1% +$1.05K 0.03% 154
2024
Q4 		$909K Sell
10,102
-447
-4% -$35.7K 0.03% 148
2024
Q3 		$655K Buy
10,549
+2
+0% +$112 0.02% 171
2024
Q2 		$564K Sell
10,547
-3
-0% -$169 0.02% 183
2024
Q1 		$628K Buy
10,550
+3
+0% +$169 0.03% 173
2023
Q4 		$627K Hold
10,547
– – 0.03% 169
2023
Q3 		$443K Hold
10,547
– – 0.02% 191
2023
Q2 		$539K Hold
10,547
– – 0.03% 176
2023
Q1 		$615K Sell
10,547
-27
-0.3% -$1.61K 0.03% 165
2022
Q4 		$586K Hold
10,574
– – 0.03% 165
2022
Q3 		$565K Hold
10,574
– – 0.03% 160
2022
Q2 		$607K Buy
10,574
+27
+0.3% +$2.19K 0.03% 152
2022
Q1 		$1.13M Hold
10,547
– – 0.06% 124
2021
Q4 		$1.61M Hold
10,547
– – 0.09% 103
2021
Q3 		$2.71M Hold
10,547
– – 0.16% 67
2021
Q2 		$2.95M Sell
10,547
-6,214
-37% -$1.39M 0.17% 62
2021
Q1 		$3.39M Buy
16,761
+22
+0.1% +$5.1K 0.22% 45
2020
Q4 		$3.72M Hold
16,739
– – 0.25% 42
2020
Q3 		$3.6M Hold
16,739
– – 0.28% 43
2020
Q2 		$2.88M Hold
16,739
– – 0.27% 43
2020
Q1 		$1.55M Hold
16,739
– – 0.15% 58
2019
Q4 		$1.24M Hold
16,739
– – 0.11% 78
2019
Q3 		$1.04M Hold
16,739
– – 0.09% 105
2019
Q2 		$832K Buy
+16,739
New +$894K 0.07% 123

Other funds holding DOCU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aspiriant LLC's DOCU Position: Q1 2026 in Review

Aspiriant LLC sold out of DocuSign (DOCU) in Q1 2026, closing a stake of 6,183 shares — an estimated $423K sold.

Aspiriant LLC first reported a position in DOCU in Q2 2019 and held it in 27 quarters. The position peaked at $3.72M in Q4 2020. 703 funds tracked by Wall St. Rank hold DOCU as of Q1 2026.

  • Aspiriant LLC reported no remaining DocuSign position as of Q1 2026 after selling out during the quarter.
  • Aspiriant LLC sold 6,183 DocuSign shares in Q1 2026, an estimated $423K.
  • Aspiriant LLC first reported a position in DocuSign in Q2 2019 and held it in 27 quarters.
  • Aspiriant LLC's DocuSign position peaked at $3.72M in Q4 2020.
  • 703 funds tracked by Wall St. Rank held DocuSign as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.